A Comparison of Depression Screening Instruments in Hepatitis C and the Impact of Depression on Somatic Symptoms

2011 ◽  
Vol 52 (5) ◽  
pp. 433-440 ◽  
Author(s):  
Sanjeev Sockalingam ◽  
Diana Blank ◽  
Abdulqader Al Jarad ◽  
Fahad Alosaimi ◽  
Gideon Hirschfield ◽  
...  
2005 ◽  
Vol 42 (5) ◽  
pp. 639-645 ◽  
Author(s):  
María Buti ◽  
Ramón San Miguel ◽  
Max Brosa ◽  
Juan M. Cabasés ◽  
Montserrat Medina ◽  
...  

Viruses ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 432
Author(s):  
Lorenzo Onorato ◽  
Mariantonietta Pisaturo ◽  
Mario Starace ◽  
Carmine Minichini ◽  
Alessandra Di Fraia ◽  
...  

The availability of all oral direct acting antiviral agents (DAAs) has revolutionized the management of HCV infections in recent years, allowing to achieve a sustained virological response (SVR) in more than 95% of cases, irrespective of hepatitis C Virus (HCV) genotype or staging of liver disease. Although rare, the failure to the latest-generation regimens (grazoprevir/elbasvir, sofosbuvir/velpatasvir, pibrentasvir/glecaprevir) represents a serious clinical problem, since the data available in the literature on the virological characteristics and management of these patients are few. The aim of the present narrative review was to provide an overview of the impact of baseline RASs in patients treated with the latest-generation DAAs and to analyze the efficacy of the available retreatment strategies in those who have failed these regimens.


PLoS ONE ◽  
2011 ◽  
Vol 6 (8) ◽  
pp. e23830 ◽  
Author(s):  
Hossein Poustchi ◽  
Saeed Esmaili ◽  
Ashraf Mohamadkhani ◽  
Aghbibi Nikmahzar ◽  
Akram Pourshams ◽  
...  

2015 ◽  
Vol 18 (4) ◽  
pp. 787-798 ◽  
Author(s):  
Francisco J. Limon ◽  
Angela L. Lamson ◽  
Jennifer Hodgson ◽  
Mark Bowler ◽  
Sy Saeed

2007 ◽  
Vol 14 (4) ◽  
pp. 255-259 ◽  
Author(s):  
C. Goulding ◽  
C. O'Brien ◽  
H. Egan ◽  
J. E. Hegarty ◽  
G. McDonald ◽  
...  

2021 ◽  
Vol 10 ◽  
pp. 100129
Author(s):  
Nick Scott ◽  
Thin Mar Win ◽  
Tom Tidhar ◽  
Hla Htay ◽  
Bridget Draper ◽  
...  

2011 ◽  
Vol 57 ◽  
pp. S202-S207 ◽  
Author(s):  
Fabianna Bahia ◽  
Vinicius Novais ◽  
Jennifer Evans ◽  
Chloe Le Marchand ◽  
Eduardo Netto ◽  
...  

2021 ◽  
pp. 152483992110660
Author(s):  
Shuying Sha ◽  
Mollie Aleshire

Primary care providers’ (PCPs) implicit and explicit bias can adversely affect health outcomes of lesbian women including their mental health. Practice guidelines recommend universal screening for depression in primary care settings, yet the guidelines often are not followed. The intersection of PCPs’ implicit and explicit bias toward lesbian women may lead to even lower screening and diagnosis of depression in the lesbian population than in the general population. The purpose of this secondary analysis was to examine the relationship between PCPs’ implicit and explicit bias toward lesbian women and their recommendations for depression screening in this population. PCPs ( n = 195) in Kentucky completed a survey that included bias measures and screening recommendations for a simulated lesbian patient. Bivariate inferential statistical tests were conducted to compare the implicit and explicit bias scores of PCPs who recommended depression screening and those who did not. PCPs who recommended depression screening demonstrated more positive explicit attitudes toward lesbian women ( p < .05) and their implicit bias scores were marginally lower than the providers who did not recommend depression screening (p = .068). Implications for practice: Depression screening rates may be even lower for lesbian women due to implicit and explicit bias toward this population. Training to increase providers’ awareness of bias and its harm is the first step to improve primary care for lesbian women. Policies must protect against discrimination based on sexual orientation or gender identity.


Sign in / Sign up

Export Citation Format

Share Document